Mesoblast (MESO) Net Equity Issued and Repurchased (2017 - 2022)

Mesoblast (MESO) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $45.1 million in Q3 2022.

• For the quarter ending Q3 2022, Net Equity Issued and Repurchased rose 30556.46% year-over-year to $45.1 million; the trailing twelve-month figure through Mar 2023 stood at $45.1 million (up 4946.47% YoY), and the FY2022 full-year result was $209000.0, down 99.8% from the prior year.
• Net Equity Issued and Repurchased climbed to $45.1 million in Q3 2022, from $62000.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $96.0 million in Q1 2021 to a low of $34000.0 in Q1 2018.
• A 5-year average of $23.3 million and a median of $4.8 million in 2020 frame the typical range for Net Equity Issued and Repurchased.
• Across the five-year window, Net Equity Issued and Repurchased sank 99.27% in 2021 and jumped 30556.46% in 2022, its largest moves.
• Tracing MESO's Net Equity Issued and Repurchased over 5 years: stood at $20.2 million in 2018, then surged by 151.13% to $50.8 million in 2019, then sank by 97.18% to $1.4 million in 2020, then plunged by 95.67% to $62000.0 in 2021, then surged by 72585.48% to $45.1 million in 2022.
• Business Quant data shows MESO's Net Equity Issued and Repurchased at $45.1 million in Q3 2022, $62000.0 in Q4 2021, and $147000.0 in Q3 2021.